Schramm A, De Gregorio N, Widschwendter P, et al. Targeted Therapies in HER2-Positive Breast Cancer- a Systematic Review. Breast Care (Basel) 2015 ; 10 : 173.
Piccart-Gebhart MJ, Procter M, Leyland Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005 ; 353: 1659.